Showing 30 of 4110 posts
JTC reports trading in line with expectations while regulatory work continues on its £13.40-per-share acquisition.
JoshuaJuly 30, 2026
MyCelx remains on track for $11.0 million of 2026 revenue, but project timing, working capital and potential financing remain key risks.
JoshuaJuly 30, 2026
Quadrise and Licella have set a clearer testing pathway for combining HTL bio-oil with bioMSAR fuels for the maritime market.
JoshuaJuly 30, 2026
Oakley Capital Investments grew NAV per share by 6% in the first half, supported by earnings growth, while shareholder returns fell 16%.
JoshuaJuly 30, 2026
Henderson Smaller Companies raised its dividend for a 23rd year as buybacks helped offset marginal benchmark underperformance.
JoshuaJuly 30, 2026
Anglo American lifted first-half EBITDA by 35%, supported by copper, stronger cash flow and progress simplifying its mining portfolio.
JoshuaJuly 30, 2026
Vesuvius improved cash generation and Foundry profits in H1 2026, although operational problems held back its larger Steel division.
JoshuaJuly 30, 2026
Foxtons' recurring lettings revenues limited the H1 sales downturn, although profit and cash flow fell while net debt increased.
JoshuaJuly 30, 2026
Rentokil delivered higher profit, cash flow and dividends, although slower US growth means management is prioritising investment over near-term margins.
JoshuaJuly 30, 2026
LSEG delivered record first-half results, raised its 2026 margin guidance and outlined total completed and planned buybacks of £3.45 billion.
JoshuaJuly 30, 2026
Hammerson raised full-year guidance after rental income and EPRA earnings grew strongly, while its interim dividend increased by 22%.
JoshuaJuly 30, 2026
Lords Group Trading held H1 revenue broadly flat, but weak underlying demand and cautious FY26 guidance highlight the pressure on its markets.
JoshuaJuly 30, 2026
EKF Diagnostics held first-half revenue broadly steady while improving margins, growing adjusted EBITDA and generating further cash.
JoshuaJuly 30, 2026
Wilmington expects revenue of £120 million and adjusted profit before tax of at least £31 million after strong growth from Conversia.
JoshuaJuly 30, 2026
SEGRO grew adjusted EPS by 6.6% in H1 2026, although a 1.2% portfolio valuation decline pushed net tangible assets lower.
JoshuaJuly 30, 2026
Lloyds delivered stronger income, flat operating costs and robust capital generation, supporting a 30% dividend rise and £1.0 billion buyback.
JoshuaJuly 30, 2026
Drax's first-half earnings fell on lower power prices, but the dividend rose and management maintained its full-year outlook.
JoshuaJuly 30, 2026
Informa delivered solid underlying growth and maintained guidance, although reported earnings and free cash flow declined year on year.
JoshuaJuly 30, 2026
Ondo InsurTech delivered strong recurring and US revenue growth, although widening losses and continued funding needs remain key risks.
JoshuaJuly 30, 2026
Brave Bison is offering 135p in cash and 2.04 new shares per System1 share, implying a value of 327p and a £43.1 million valuation.
JoshuaJuly 30, 2026
AIB Group delivered €939 million of profit and raised parts of its 2026 guidance as lending, deposits and shareholder returns increased.
JoshuaJuly 30, 2026
Shield Therapeutics delivered $30.4 million of H1 revenue and stayed profitable, but Q2 revenue and cash declined against earlier periods.
JoshuaJuly 30, 2026
ZOO Digital's FY26 revenue fell 14.7%, but restructuring lifted adjusted EBITDA to $4.0 million and helped the group generate cash.
JoshuaJuly 30, 2026
Seplat Energy has agreed to sell a 10% JV interest for US$281.6 million, with proceeds earmarked for debt reduction and shareholder returns.
JoshuaJuly 30, 2026
Elementis lifted first-half profit by 16.4%, reached a 23.0% adjusted margin and maintained its full-year outlook despite cash flow pressures.
JoshuaJuly 30, 2026
Watkin Jones secured six contracts worth around £60 million, but second-half profit progression still relies on final-quarter deals.
JoshuaJuly 30, 2026
Vanquis grew lending and profit in the first half, but weaker credit card yields and higher impairments led management to reduce returns guidance.
JoshuaJuly 30, 2026
Barclays is returning up to £1 billion through a share buy-back running until January 2027, subject to regulatory approval.
JoshuaJuly 29, 2026
Imaging Biometrics made a £73,852 first-half profit, but modest revenue growth and a £49,384 cash balance leave important questions.
JoshuaJuly 29, 2026
Kooth expects adjusted EBITDA to more than triple in the first half, despite revenue falling as California development income tapers.
JoshuaJuly 29, 2026